Sg3 Management, LLC Elanco Animal Health Inc Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.63 - $26.62 $166,855 - $226,270	-8,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $36,975 - $43,500	-1,500 Reduced 15.0%	8,500 $222,000
Q4 2021 Feb 15, 2022	BUY	$27.74 - $34.09 $277,400 - $340,900	10,000 New	10,000 $284,000
Q1 2021 May 17, 2021	SELL	$27.85 - $34.49 $111,400 - $137,960	-4,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $110,120 - $135,160	4,000 New	4,000 $123,000
Q2 2019 Aug 09, 2019	SELL	$31.11 - $34.79 $4.74 Million - $5.31 Million	-152,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $4.42 Million - $5.01 Million	152,500 New	152,500 $4.89 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.